Elysium Health Stock
Scientific health products
Sign up today and learn more about Elysium Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Elysium Health Stock
Elysium Health’s mission is to solve the challenges in health with science, to help people live healthier and longer. Elysium works directly with scientists, clinicians and health professionals worldwide the world to translate advances in science and technology into innovative health products that work. Our product development pipeline begins with research and development, continues with preclinical studies, and culminates with human clinical trials to demonstrate the safety and efficacy of products. Throughout this process, Elysium’s focus is to develop compounds found in nature that allow people to support their health proactively. Elysium is guided by a Scientific Advisory Board, which includes multiple winners of the Nobel Prize, as well as researchers and doctors who are experts in chemistry, physiology, neuroscience, complex chemical systems, biochemistry, and many other fields of study. Basis, Elysium Health’s first product, is a proprietary formulation of two ingredients designed to support long-term health at the cellular level. Basis is clinically proven to increase NAD+ levels, which decline with age. NAD+ is required for energy creation, regulating circadian rhythms, maintaining healthy DNA, and hundreds of other biological functions. Learn more via our science journal Endpoints: https://endpoints.elysiumhealth.com
Investors
General Catalyst Partners
Snap, Jet, Stripe, Anduril Industries, Relativity Space, Devoted Health, Lacework, Oscar Health, Circle, Hopin
Breyer Capital
Oscar Health, Circle, Shield AI, Stash Financial, Prosper Marketplace, Mark43, C3 IoT, Grammarly, Etsy, Cleerly
Morningside Group
Silicon Valley Bank
One97, Olive, FireEye, Weee!, Workrise, Fair, project44, Plume Design, BetterUp, Welltok
Sound Ventures
Bird, ConsenSys, Noom, Chainalysis, SentinelOne, Capsule, Fundbox, MoonPay, Cedar, Mark43
Funding History
October 2015 | $1.1M |
---|---|
October 2015 | $6.2M |
October 2016 | $22.0M |
Management
CEO & Co-Founder
Eric Marcotulli
COO & Co-Founder
Dan Alminana
Chief Scientist & Co-Founder
Leonard Guarente
Chief Design Officer
Andrew Lin
Press
cointelegraph - Feb, 16 2024
Elysium unveils the “Elysium Accelerator Program”: Empowering Web3 game developmentledgerinsights - Jul, 1 2023
Nomura’s digital asset biz Laser acquires post trade firm Elysiumgamedeveloper - Dec, 10 2022
Disco Elysium exec producer drops lawsuit against ZA/UM majority shareholderglobenewswire - Nov, 30 2022
Elysium Lila Metaverse Stands Out in the Virtual Ecosystem with Spectacular Featurestrib - Oct, 24 2022
Disco Elysium writer is suing developer ZA/UM